|Publication number||US20050209555 A1|
|Application number||US 10/803,214|
|Publication date||Sep 22, 2005|
|Filing date||Mar 18, 2004|
|Priority date||Mar 18, 2004|
|Also published as||US8109902, US20100042044, WO2005089500A2, WO2005089500A3|
|Publication number||10803214, 803214, US 2005/0209555 A1, US 2005/209555 A1, US 20050209555 A1, US 20050209555A1, US 2005209555 A1, US 2005209555A1, US-A1-20050209555, US-A1-2005209555, US2005/0209555A1, US2005/209555A1, US20050209555 A1, US20050209555A1, US2005209555 A1, US2005209555A1|
|Inventors||Lance Middleton, Scott Reed, Jared Walkenhorst|
|Original Assignee||Lance Middleton, Scott Reed, Jared Walkenhorst|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (10), Referenced by (28), Classifications (16), Legal Events (1)|
|External Links: USPTO, USPTO Assignment, Espacenet|
This invention relates to systems and methods for mixing fluids, and particularly medical fluids. More specifically, the invention relates to improvements in syringe-to-syringe mixing systems.
Several systems have been developed for on-site mixing and dispensing of multi-part medical and dental compositions. One system uses dual-cartridge syringes with static mix tips. These systems are generally not adequate for mixing polymers with high mix ratios. A further drawback is that a considerable amount of material is wasted in the mix tip, which may not be problematic for low cost fluid compounds but is potentially prohibitive for expensive materials, such as an injectable disc nucleus material.
Another known system, known as continuous flow systems, uses an electromechanical apparatus that drives a mix tip for controlled mixing of the fluids. Continuous flow systems are best suited for “assembly line” production and are excessive and too expensive for mixing single batches of fluid compounds.
A system that is very compatible for mixing small batches includes two medical syringes connected by an adapter so that fluids can be pushed back and forth between the syringes. One such prior system is depicted in
Syringe-to-syringe adapters like the adapter 17 have been used to couple a large reservoir syringe with a small dose syringe to simply transfer fluid from one to the other. These adapters have also been used to sequentially couple different syringes to a single syringe, each of the different syringes carrying a different fluid, or in some cases a granular compound to mix with the fluid in the single syringe. In some cases, the two syringes contain different fluids that must be thoroughly mixed. This mixing occurs by alternately depressing the plungers 15 of the opposing syringes 10 so that the fluids flow back and forth through the adapter. Once the fluid transfer or mixing is complete, the syringes are uncoupled and one or both of the syringes can be used as an applicator or injection device.
For many types of fluids and fluid compounds, this mixing approach is sufficient. For instance, many emulsions are prepared through syringe-to-syringe mixing. In these prior devices, the constant diameter passageway 18 in the adapter 17 allows full uniform flow of the fluid through the adapter, and the resultant mixture is complete enough for the particular medical application. One drawback of these prior systems is that they require relatively high plunger forces when mixing viscous fluids, which can lead to user fatigue. Another problem is that it is time consuming to achieve uniform distribution of micro-droplets within a fluid mixture.
Furthermore, in certain medical applications, the degree of mixing that can be accomplished with prior adapters, such as the adapter 17, is less than optimum. This problem manifests itself where high mix ratios are involved. For instance, certain injectable disc nucleus (IDN) compositions can have mix ratios between two constituents (i.e., polymer and cross-linker) greater than 10:1, and even greater than 100:1. The entire composition fails if the lower concentration constituent (such as the cross-linker in the case of an IDN) is not fully mixed within the other constituent (the polymer).
This mixing problem is also critical where the fluids combine to form a curable composition. In this case, as the different fluids are mixed they begin to cure, congeal or harden. For some materials, the curing time is sufficiently long so that the mixture can be cycled back and forth between the syringes enough times to ensure complete mixing of the constituents. For instance, many bone cements can be mixed using these types of prior devices.
However, the time necessary to achieve complete mixing is prohibitive for some curable materials that cure relatively quickly. If these types of materials are not dispensed in a timely manner, the mixture is worthless. For example, certain chemical compositions have been developed for the replacement of body tissues. One type of composition, known as hydrogels, is formed by mixing a polymer with a cross-linker. The resulting mixture starts to cure immediately when the constituents come into contact. For some hydrogels, the curing time is under two minutes. In these cases, it is imperative that the fluid mixing occur as quickly and completely as possible so that the surgeon has enough time remaining to inject the hydrogel at the surgical site.
The short curing times essentially prohibit mixing the constituents in any system other than a system that permits immediate injection of the mixture. In other words, syringe-to-syringe mixing is the most viable alternative for fluid compounds having short curing times.
Consequently, there is a need for a syringe-to-syringe system that yields complete mixing in mixing conditions that include one or more of the following parameters:
The present invention provides a syringe-to-syringe mixing apparatus that addresses these unresolved needs. In one embodiment, the mixing apparatus comprises an elongated body defining a passageway therethrough and configured at its opposite ends to engage a respective syringe thereat. The passageway communicates with the interior volume of each syringe so that fluid in each syringe can pass back and forth therebetween. In one feature of the invention, the mixing apparatus includes a flow modifying element disposed in the passageway that is configured to modify the flow of a fluid passing therethrough from syringe to syringe. The flow modifying element is configured to modify the fluid flow by increasing the flow velocity, disrupting the fluid flow or introducing turbulence.
In one preferred embodiment the flow modifying element is integrally formed in the body. In certain embodiments, the passageway defines a first flow area and the flow modifying element includes a restriction configured to increase the flow velocity therethrough, in which the restriction defines a second flow area less than the first flow area. In a specific embodiment, the first flow area is about five times greater than the second flow area.
The restriction assumes a variety of forms effective to disrupt the fluid flow and promote complete fluid mixing. For instance, the passageway and the restriction are substantially cylindrical in one embodiment, with the restriction constituting a nozzle. In other embodiments, the restriction is in the form of a slit, a multi-lobed opening, or a plurality of nozzles communicating between end portions of the passageway. In a further embodiment, the passageway includes a first portion adjacent one end of the passageway and a second portion adjacent the opposite end of the passageway, the first and second portions having longitudinal axes offset from each other. The restriction is then defined by an intersection between the first and second portions of the passageway.
In another aspect of certain embodiments of the invention, the body of the syringe-to-syringe mixing apparatus defines a mixing chamber between the flow modifying element and at least one of the opposite ends of the passageway. The passageway can be configured to receive a portion of the syringe tip therein, with the mixing chamber defined between the flow modifying element and the syringe tip when the tip is received within the passageway.
In some embodiments of the invention, the flow modifying element includes at least two nozzles in the passageway, each configured to increase the flow velocity therethrough. The body defines an intermediate mixing chamber between successive ones of the at least two nozzles. The intermediate mixing chamber defines a first flow area and each of the at least two nozzles defines a second flow area less than the first flow area.
In yet another aspect of the invention, the flow modifying element includes at least two baffles forming a serpentine flow path through the passageway. The flow modifying element may also include a plurality of pins traversing the passageway to disrupt the fluid flow through the mixing apparatus.
In some applications of the invention it is desirable to add a small quantity of an additional constituent to the fluid being mixed between the opposing syringes. Consequently, the invention contemplates means for introducing this constituent into the fluid flowing through the mixing apparatus. In one embodiment of the invention, the mixing apparatus body defines an orifice in communication with the passageway between the opposite ends thereof. The mixing apparatus is configured to receive a device for injecting the constituent through the orifice, such as a syringe.
In one feature of this embodiment, the orifice is a sealed orifice. The apparatus can further comprise a valve covering the orifice to prevent flow of the constituent therethrough. In one embodiment, the valve is a septum covering the orifice. The septum is adapted to be penetrated by a fluid introduction component, such as a syringe needle. In one specific embodiment, the septum is formed of a self sealing material, such as SILASTIC®, that seals around a needle when pierced and resiliently closes when the needle is removed. In another specific embodiment the septum includes a slit that is resiliently sealed by the septum material but can open upon pressure from the fluid introduction component.
The mixing apparatus is configured to accept the tips of opposing syringes. Thus, the passageway of the mixing apparatus body can be configured for a fluid-tight press-fit engagement with the tips of the syringes. The body can also include fittings at its opposite ends that are configured to engage the syringe. For instance, the fittings can be Luer fittings to engage complementary fittings on the syringes.
The present invention further contemplates an improvement to a syringe-to-syringe mixing apparatus comprising a nozzle element disposed within the tip of a syringe. The nozzle element defines a passageway therethrough in communication with the interior volume of the syringe and includes a restriction in at least one end of the nozzle element adjacent the interior volume of the syringe. The restriction is configured to increase the flow velocity therethrough. In one embodiment, restriction includes at least a portion of the passageway having a flow area that decreases toward the interior volume of the syringe.
In certain embodiments, the nozzle element is an insert configured to be mounted within the tip of the syringe. The insert includes a retaining flange at an opposite end of the nozzle element, wherein the retaining flange is configured to engage the end of the syringe tip. The insert can be configured to be inserted into the tip of the syringe through the interior volume of the syringe. In another embodiment, the nozzle element is integrally formed within the tip of the syringe.
The invention further provides in a syringe-to-syringe mixing system of the type having two syringes adapted to reciprocally pass fluid therebetween until mixed, a mixing apparatus comprising means for modifying the flow of fluid between the two syringes. This means is adapted to communicate with each of the two syringes and is preferably configured for disposition between the two syringes.
In one embodiment, this means for modifying the flow of fluid can include an elongated body, adapted at its ends to engage a corresponding one of the two syringes. The elongated body defines a fluid passageway in communication with the two syringes and a restriction within the passageway. The restriction can be in the form of a nozzle adapted to significantly increase the fluid flow velocity through the apparatus.
In another embodiment, the means modifying the flow of fluid is configured for disposition within one of the two syringes. In this embodiment, the means for modifying the flow of fluid can include a nozzle insert configured for engagement within the tip of one of the two syringes.
It is one object of the present invention to provide a syringe-to-syringe mixing system that efficiently mixes at least two constituents of a fluid composition. It is one particular object to provide a mixing system that can quickly and thoroughly mix the constituents of a composition that is “time sensitive”, such as compositions that begin curing when mixed.
Another object is to provide a mixing system that can accept the introduction of small quantities of a constituent. A further object is to permit introduction of this constituent at any point in the mixing of the other constituents of the composition.
One benefit of the mixing apparatus of the present invention is that it can be used with traditional syringe-to-syringe mixing systems. Another benefit is that it provides complete and rapid mixing with minimal effort on the part of medical personnel. A further benefit of the present invention is that it is ideally suited for mixing self-curing compositions, or compositions that begin curing once the constituents come in contact with each other in appropriate ratios.
Other objects and benefits of the invention will become apparent upon consideration of the following written description, taken together with the accompanying figures.
For the purposes of promoting an understanding of the principles of the invention, reference will now be made to the embodiments illustrated in the drawings and described in the following written specification. It is understood that no limitation to the scope of the invention is thereby intended. It is further understood that the present invention includes any alterations and modifications to the illustrated embodiments and includes further applications of the principles of the invention as would normally occur to one skilled in the art to which this invention pertains.
The present invention contemplates a mixing apparatus for use with a pair of syringes, such as the syringes 10 shown in
The passageway 23 is initially sized to receive the syringe tip 14 at the opposite ends of the mixing apparatus 20. In accordance with one feature of the invention, a flow modifying element 25 is disposed within the passageway. The flow modifying element is configured to modify the flow of a fluid through the passageway, such as by increasing the flow velocity, disrupting the fluid flow or introducing turbulence. In accordance with the embodiment of the invention shown in
The engagement between the syringe tip 14 and the fittings 28 of the mixing apparatus is configured to provide a mixing chamber 24 on each side of the nozzle 26. The nozzle operates to increase the flow velocity of fluid passing therethrough. The increase in cross-sectional area from the nozzle to the mixing chambers 24 preserves the greater fluid shear rates generated by the nozzle. A significant amount of fluid mixing occurs in the mixing chambers 24, but fluid mixing continues as the fluid is pushed from one syringe to the other.
In accordance with one feature of this embodiment, the length of the nozzle is comparatively short relative to the length of the mixing chambers 24 and passageway 23. Keeping the length of the nozzle to a minimum reduces the force that must be applied to drive the fluid through the nozzle. In a specific embodiment, the length of the nozzle is about twice its effective diameter. The nozzle 26 in this embodiment has an effective diameter of about 0.05 inches, and a length of about 0.1 inches. The passageway 23 has an effective diameter that is about five times greater than the nozzle diameter.
Other embodiments of the mixing apparatus include different nozzle configurations for the flow modifying element that do not employ as gradual a change as the embodiment of
The mixing apparatus 30 shown in
In the embodiment shown in
Variations in the configuration of the nozzle 26 (
In a variation of the lobed nozzle concept, the flow modifying element for a mixing apparatus 45 of
In another approach, the flow modifying element includes a series of baffles interposed in the fluid flow path between the syringes. For example, as depicted in
The mixing apparatus 60 shown in
The embodiments shown in
The pins have an effective width that is sufficient to disrupt the fluid flow through the passageway, but not so large that they greatly increase the flow resistance of the mixing apparatus. The pins generate eddies downstream of the pins with enough flow velocity through the passageway, which help mix the fluid constituents. Although the embodiment illustrated in
The mixing apparatus 70 shown in
In using the apparatuses shown in
Fluid mixing occurs by alternately depressing the plungers 15 of the two syringes. The speed and number of alternating plunger movement depends upon the type of material being mixed. For some polymer compositions, ten cycles in ten seconds is sufficient for complete mixing of the fluid constituents.
The mixing adapters depicted in the figures are all “in line”, meaning that the longitudinal axes of the syringes and the mixing apparatus are coincident. While this arrangement is believed to be optimum, it is possible to configure the mixing apparatuses to mate with non-aligned syringes. With this alternative configuration, at least a portion of at least one of the mixing chambers will be configured to change the direction of the fluid flow into the non-aligned syringe.
In the embodiments of the invention illustrated in
The present invention contemplates an alternative embodiment in which most of the fluid mixing occurs in the syringes themselves. In one exemplary embodiment shown in
In accordance with this alternative embodiment, a nozzle insert 90 is inserted into the tip 14 of at least one of the syringes 10. As best seen in
Again as seen in
The benefits of this nozzle insert 90 can be discerned by the comparison in
In an alternative approach, the restriction can be integrated into the syringe tip itself, as illustrated in
While the preferred embodiment contemplates a restriction 94 that produces an increase in flow velocity, another alternative is to disrupt the fluid flow into the syringe. Thus, the restriction can be replaced by the flow modifying elements depicted in
The septum orifice 101 provides means for introducing an additional fluid into a mixture, where one or more other fluids are contained within the syringes 10, 10 a. In addition, the orifice 101 supplies an avenue for the introduction of a low ratio fluid constituent. For instance, where the mix ratio is 100:1 and above, the volume of one constituent is extremely small compared to the volume of the constituent contained in one of the syringes 10. Carrying this low ratio fluid in one of the syringes 10 may not result in a complete mixing of the two fluids. Thus, the introduction of the low ratio fluid directly into the fluid flow passing through the mixing apparatus 80 ensures that the low ratio fluid will be entrained within the higher volume fluid.
Although the septum feature is depicted in combination with the nozzle insert, the septum can be integrated into any of the mixing apparatuses shown in
The septum provides a ready interface for needle injection of a fluid into the mixing stream. Alternatively, the septum bore 100 can be used as a reservoir to hold a fluid constituent. The orifice 101 can be sized and arranged within the body 82 to act as a venturi orifice. As fluid flows past the orifice 101, the reduced pressure will draw fluid from the bore/reservoir 100 to mix with the fluid passing through the passageway 83. Optimally, where the orifice serves as a venturi opening, the orifice 101 is positioned at a narrowing in the passageway, such as at the nozzle 26 of the apparatus 20 shown in
In one application of the mixing apparatus 80 shown in
Next, the plunger 14 is removed from the other syringe 10 a and the nozzle insert 90 is mounted on an insertion tool 126. As depicted in
About 2 ml of the polymer in the first syringe 10 is transferred into the second syringe 10 a and that syringe is detached from the mixing apparatus. Air is again purged from both syringes with care given to ensuring that a positive meniscus is formed at the tip of the second syringe 10 a and at the open end of the mixing apparatus. The assembly is completed by re-attaching the second syringe to the mixing apparatus.
The polymer in the second syringe 10 a is then shifted back to the first syringe 10 and the filled assembly is placed aside until the final IDN composition is needed for introduction into the patient. When that point arrives, a third syringe 110 loaded with a cross-linker is provided. The needle 111 punctures the septum 103 and the full pre-measured quantity of cross-linker is injected into the mixing apparatus 80. This solution is then mixed by cycling the syringe plungers 14 back and forth for ten cycles in 7-10 seconds, ending with the entire volume in the first syringe 10. The surgeon then has a limited amount of time to inject the mixed IDN composition into the patient's disc, under 1½ minutes for certain compositions. The first syringe is detached from the mixing apparatus and an injection needle mounted to the syringe to accomplish the disc injection.
An alternative mixing apparatus 130 is illustrated in
In this embodiment, the apparatus 130 includes a pair of connectors 150 that connect the body 132 to the two syringes and that traps the head 147 of each nozzle insert 145 within the body. Each connector includes a threaded fitting that mates with threads defined in the open ends of the passageway 133. As the connector 150 is threaded into the passageway it clamps the head 147 of the insert 145 within the body. The connectors 150 also include a Luer fitting 154 for mating with the Luer fitting 11 of each syringe. The Luer fittings 154 define a channel 156 for receiving the syringe tip 14 therein. The connectors 150 may include a thumb wheel 158 to facilitate threading the fittings 152,154 into their respective mating fittings.
In an alternative configuration, the syringe tip can be provided with external threads to engage the internal threads in the passageway 133 of the body 132. With this alternative, the body can be mounted on the tip 14 without the connector 150, and can directly trap the head 147 of the insert 145 between the body and the end of the syringe tip.
The mixing apparatus 130 demonstrates that a nozzle insert can be provided in both syringes, rather than in one syringe only. The mixing apparatus also contemplates a longer fluid flow path between the syringes than most of the prior embodiments. This longer flow path can provide beneficial mixing characteristics for certain fluid compositions.
In a further modification, a one-piece septum component 180 can be engaged within a mixing apparatus 170, as shown in
In a modification from this prior embodiment, the septum bore 172 defines a septum seat 176 and an enlarged cavity 178. The septum component 180 includes a septum portion 182 that bears against the septum seat 176 directly above the orifice 174. The component 810 further includes an enlarged flange 186 that is sized to expand into the enlarged cavity 178 when the septum portion is seated on the septum seat. The septum component 180 is formed of a resiliently compressible material, such as SILASTIC®, so that the flange 186 can be compressed to squeeze through upper portion of the bore 172 and then resiliently expand outward into the cavity 178. The flange is configured to hold the septum component 180 within the septum bore 172 and maintain a fluid-tight seal between the septum portion 182 and the septum seat 176.
The septum component 180 defines an open bore 184 that terminates at the septum portion 182. The bore 184 serves as a guide for a syringe, such as the syringe 110 depicted in
While the invention has been illustrated and described in detail in the drawings and foregoing description, the same should be considered as illustrative and not restrictive in character. It is understood that only the preferred embodiments have been presented and that all changes, modifications and further applications that come within the spirit of the invention are desired to be protected.
For example, the nozzle insert 90 can be combined with a mixing apparatus 20 or its variations shown in
As described above, the syringe-to-syringe mixing systems are hand supported. Gripping elements can be added to the syringes to facilitate gripping of the syringes and manipulation of the syringe plungers. Alternatively, a fixture can be provided to support the syringes and/or mixing apparatus. Furthermore, while the illustrated embodiments contemplate manually operated syringes, the mixing apparatuses and nozzle inserts can also be used with powered fluid dispensing systems.
The principles of the present invention can also be employed to mix granular or particulate constituents with a fluid. In this instance, the granular constituents can be contained in one syringe and the fluid constituent in the other. The nozzle insert can be engaged within the first syringe so that the “jet flow” will agitate the granular material as the fluid is injected.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US3010705 *||Sep 26, 1960||Nov 28, 1961||Brown Ethan Allan||Emulsifiers|
|US3526391 *||Jan 3, 1967||Sep 1, 1970||Wyandotte Chemicals Corp||Homogenizer|
|US3729031 *||Dec 6, 1971||Apr 24, 1973||Mpl Inc||Liquid dispenser and plunger and method and apparatus for filling same|
|US3860218 *||Feb 13, 1973||Jan 14, 1975||Hurlimann Hans P||Treatment apparatus for compositions of matter|
|US4743229 *||Sep 29, 1986||May 10, 1988||Collagen Corporation||Collagen/mineral mixing device and method|
|US4979942 *||Oct 16, 1989||Dec 25, 1990||Johnson & Johnson Medical, Inc.||Two component syringe delivery system|
|US5425580 *||Aug 2, 1994||Jun 20, 1995||Byk Gulden Lomberg Chemische Fabrik Gmbh||Dosage form for micro-bubble echo contrast agents|
|US5951160 *||Nov 20, 1997||Sep 14, 1999||Biomet, Inc.||Method and apparatus for packaging, mixing and delivering bone cement|
|US6062722 *||Oct 21, 1997||May 16, 2000||Micron Communications, Inc.||Fluid mixing and withdrawing methods|
|US6234196 *||Feb 19, 1999||May 22, 2001||Ultradent Products, Inc.||Mixing adaptor and system|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US7421879 *||Nov 17, 2004||Sep 9, 2008||Fresenius Medical Care Deutschland Gmbh||Device and method for transferring a reference liquid into a measurement appliance|
|US7556650||Jun 29, 2005||Jul 7, 2009||Spine Wave, Inc.||Methods for injecting a curable biomaterial into an intervertebral space|
|US7666159 *||May 24, 2007||Feb 23, 2010||Eurosets S.R.L.||Venous reservoir in an extracorporeal blood circuit|
|US7722579||Jun 29, 2005||May 25, 2010||Spine Wave, Inc.||Devices for injecting a curable biomaterial into a intervertebral space|
|US7740660||Jun 29, 2005||Jun 22, 2010||Spine Wave, Inc.||Methods for treating defects and injuries of an intervertebral disc|
|US7753338||Oct 22, 2007||Jul 13, 2010||Baxter International Inc.||Luer activated device with minimal fluid displacement|
|US7789913||Jun 29, 2005||Sep 7, 2010||Spine Wave, Inc.||Methods for injecting a curable biomaterial into an intervertebral space|
|US7837733||Jun 29, 2005||Nov 23, 2010||Spine Wave, Inc.||Percutaneous methods for injecting a curable biomaterial into an intervertebral space|
|US7862537 *||Feb 13, 2006||Jan 4, 2011||Medimop Medical Projects Ltd.||Medical device for in situ liquid drug reconstitution in medicinal vessels|
|US7862538||Feb 4, 2008||Jan 4, 2011||Incept Llc||Surgical delivery system for medical sealant|
|US7909873||Dec 14, 2007||Mar 22, 2011||Soteira, Inc.||Delivery apparatus and methods for vertebrostenting|
|US8337557||Jun 29, 2005||Dec 25, 2012||Spine Wave, Inc.||Apparatus and kit for injecting a curable biomaterial into an intervertebral space|
|US8551068 *||Aug 21, 2009||Oct 8, 2013||Circle Biologics, Inc.||Fluid management devices and methods|
|US8657481||Jan 15, 2010||Feb 25, 2014||Spine Wave, Inc.||Systems and methods for mixing fluids|
|US20050132774 *||Nov 17, 2004||Jun 23, 2005||Gerhard Mager||Device and method for transferring a reference liquid into a measurement appliance|
|US20060004326 *||Jun 29, 2005||Jan 5, 2006||Keith Collins||Apparatus and kit for injecting a curable biomaterial into into an intervertebral space|
|US20060004458 *||Jun 29, 2005||Jan 5, 2006||Keith Collins||Methods for injecting a curable biomaterial into an intervertebral space|
|US20060009778 *||Jun 29, 2005||Jan 12, 2006||Keith Collins||Methods for treating defects and injuries of an intervertebral disc|
|US20060009851 *||Jun 29, 2005||Jan 12, 2006||Keith Collins||Percutaneous methods for injecting a curable biomaterial into an intervertebral space|
|US20110060361 *||Sep 8, 2010||Mar 10, 2011||Baxter International Inc.||Reconstitution and applicator system for wound sealant product|
|US20110112543 *||Aug 28, 2008||May 12, 2011||Robert Palazzolo||Bone cement mixing and delivery system and methods of use thereof|
|US20110230856 *||Aug 21, 2009||Sep 22, 2011||Kyle Matthew R||Fluid management devices and methods|
|US20130253465 *||Nov 28, 2011||Sep 26, 2013||Sanofi-Aventis Deutschland Gmbh||Dispense Interface Component for a Drug Delivery Device|
|US20140020788 *||Sep 20, 2013||Jan 23, 2014||Circle Biologics, Inc.||Fluid management devices and methods|
|WO2009095735A1 *||Jan 30, 2008||Aug 6, 2009||Becton Dickinson France||Dose dividing delivery device|
|WO2009117420A1 *||Mar 17, 2009||Sep 24, 2009||Jesse Bunch||Multi-mode syringe|
|WO2011087959A1 *||Jan 7, 2011||Jul 21, 2011||Spine Wave, Inc.||Systems and methods for mixing fluids|
|WO2011109915A1 *||Feb 10, 2011||Sep 15, 2011||Medmix Systems Ag||Modular filling device for an applicator|
|International Classification||A61J1/00, A61M5/178, A61M37/00, A61M5/31, A61J1/20|
|Cooperative Classification||A61J1/1418, A61J1/201, A61J1/2058, A61J1/2055, A61J1/2044, A61M5/3134, A61M5/1782, A61J1/2089, A61J1/2096|
|Jun 10, 2004||AS||Assignment|
Owner name: SPINE WAVE, INC., CONNECTICUT
Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:MIDDLETON, LANCE;REED, SCOTT;WALKENHORST, JARED;REEL/FRAME:015451/0628;SIGNING DATES FROM 20040331 TO 20040427